Blocking of Caveolin-1 Attenuates Morphine-Induced Inflammation, Hyperalgesia, and Analgesic Tolerance via Inhibiting NLRP3 Inflammasome and ERK/c-JUN Pathway

J Mol Neurosci. 2022 May;72(5):1047-1057. doi: 10.1007/s12031-022-01989-w. Epub 2022 Mar 9.

Abstract

Morphine is generally used to treat chronic pain in clinic. But long-term use of morphine can inevitably induce analgesic tolerance and hyperalgesia. Caveolin-1 is reported to affect morphine-mediated signaling transduction. However, the action mechanism of morphine-induced analgesic tolerance is still unknown. In this study, morphine-induced analgesic tolerance model was established in Sprague-Dawley rats. The effects of Caveolin-1 blocking on neuroinflammation and ERK/c-JUN pathway were then explored. Morphine can remarkably elevate the expression level of Caveolin-1. Based on paw withdrawal latency behavior test, we found that Caveolin-1 blocking can effectively attenuate morphine-induced analgesic tolerance and neuroinflammation. Activation of ERK/c-JUN significantly reversed the above influences caused by Caveolin-1 blocking. Taken together, blocking of Caveolin-1 can attenuate morphine-induced inflammation and analgesic tolerance through inhibiting NLRP3 inflammasome and ERK/c-JUN pathway.

Keywords: Analgesic tolerance; Caveolin-1; ERK/c-JUN pathway; Morphine; NLRP3 inflammasome.

MeSH terms

  • Analgesics / adverse effects
  • Analgesics, Opioid / pharmacology
  • Animals
  • Caveolin 1 / genetics
  • Caveolin 1 / metabolism
  • Hyperalgesia* / chemically induced
  • Hyperalgesia* / drug therapy
  • Inflammasomes / metabolism
  • Inflammation / drug therapy
  • Morphine* / pharmacology
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Analgesics
  • Analgesics, Opioid
  • Caveolin 1
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • Morphine